3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
6
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Neoplasms
9
Carcinoma, Non-Small-Cell Lung
7
Colorectal Neoplasms
6
Breast Neoplasms
6
Prostatic Neoplasms
5
Papillomavirus Infections
5
Ovarian Neoplasms
4
Neoplastic Cells, Circulating
4
Uterine Cervical Neoplasms
3
Uterine Cervical Dysplasia
3
Lung Neoplasms
3
Melanoma
2
Lymphoma, Follicular
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Carcinoma, Hepatocellular
2
Thymic aplasia
1
Stomach Neoplasms
1
Solid Tumor, Adult
1
Small Cell Lung Carcinoma
1
Respiratory Distress Syndrome
1
Recurrence
1
Rectal Neoplasms
1
Radiation Injuries
1
Pulmonary Disease, Chronic Obstructive
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Opioid-Related Disorders
1
Interventions
Rituximab
130
Cyclophosphamide
41
Bendamustine Hydrochloride
39
venetoclax
25
fludarabine
25
obinutuzumab
24
Lenalidomide
23
ibrutinib
22
Gemcitabine
22
Vincristine
20
Prednisone
20
tositumomab I-131
19
Doxorubicin
19
plerixafor
14
Dexamethasone
14
Granulocyte Colony-Stimulating Factor
12
pirtobrutinib
11
Brentuximab Vedotin
11
glofitamab
10
tocilizumab
9
pembrolizumab
9
ibritumomab tiuxetan
9
Etoposide
9
Azacitidine
9
polatuzumab vedotin
8
parsaclisib
8
copanlisib
8
acalabrutinib
8
Drug Therapy
8
ublituximab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Lymphoma, Non-Hodgkin
×
Blood Specimen Collection
×
Clear all
NCT05735704
2025-03-26
SANGUINE
JaxBio Ltd
Unknown
3,000 enrolled